Effect of dexmedetomidine on postoperative recovery quality and flap survival in patients undergoing oral cancer flap reconstruction

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067376

Enrollment

Unknown

Registered

2023-01-05

Start date

2023-01-10

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer

Interventions

Group 1:Dexmedetomidine

Group 2:Equal saline

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with oral cancer skin flap reconstruction; 2. Age >= 18 years old; 3. ASA grading ?~?; 4. I agree and sign the informed consent form for clinical research.

Exclusion criteria

Exclusion criteria: 1. Body mass index (BMI) >= 35 kg/m2; 2. Long-term use of glucocorticoids; 3. Those who are allergic to anesthetics; 4. People with mental and nervous diseases.

Design outcomes

Primary

Measure	Time frame
Flap complication;Quality of life;	—

Secondary

Measure	Time frame
Blood routine;Delirium occurrence;Sleep condition;Mood state and cognitive function;Pain;	—

Countries

China

Contacts

Public ContactChen Qiumiao

Guangxi Medical University College of Stomatology

754771601@qq.com+86 152 9656 4961

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026